# Erytech Pharma S.A.: Form D filings

Erytech Pharma S.A., a biotechnology company in Lyon, France, filed 3 Form D notices with the SEC between 2014 and 2015. The latest, on December 22, 2015, reports $4 million sold of a $4 million offering to 7 investors.

Find out what Erytech Pharma S.A. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Erytech%20Pharma%20S.A.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Erytech%20Pharma%20S.A.&page=%2Fdata%2Fform-d%2Fcompany%2Ferytech-pharma-s-a-1624422)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Erytech%20Pharma%20S.A.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Erytech%20Pharma%20S.A.&page=%2Fdata%2Fform-d%2Fcompany%2Ferytech-pharma-s-a-1624422)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 60 AVENUE ROCKEFELLER, Lyon, France, 69008
- Phone: 011-33-4-78-74-44-38
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: France
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1624422

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 22, 2015 | New notice | $3,954,924 | $3,954,924 | $0 | 7 | Dec 7, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624422/000162442215000002/0001624422-15-000002-index.htm) |
| Nov 10, 2014 | Amendment | Indefinite | $37,232,686 | Indefinite | 33 | Oct 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624422/000162442214000002/0001624422-14-000002-index.htm) |
| Nov 7, 2014 | New notice | Indefinite | $37,232,686 | Indefinite | 33 | Oct 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1624422/000162442214000001/0001624422-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| GIL BEYEN | Executive Officer, Director |  |
| MARTINE GEORGE | Director |  |
| SVEN ANDREASSON | Director |  |
| HILDE WINDELS | Director |  |
| YANN GODFRIN | Executive Officer, Director |  |
| ERIC SOYER | Executive Officer |  |
| PHILIPPE ARCHINARD | Director |  |
| LUC DOCHEZ | Director |  |
| JEROME BAILLY | Executive Officer |  |

[Every Form D from the week of Dec 21, 2015](https://specstream.ai/data/form-d/week/2015-12-21) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Erytech Pharma S.A. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).